Pharmaceutical technology assessment for managed care : (Record no. 599271)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03207cam a2200493 i 4500 |
| 001 - CONTROL NUMBER | |
| control field | rnd000000000071220 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | RAND |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20200811100911.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 011130s2001 caua b 000 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0833031244 |
| 027 ## - STANDARD TECHNICAL REPORT NUMBER | |
| Standard technical report number | RAND/MR-1206-SANOFI |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Sirsi) a428042 |
| 037 ## - SOURCE OF ACQUISITION | |
| Terms of availability | $20.00 |
| Form of issue | paperback |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | CstmoR |
| Transcribing agency | CstmoR |
| 043 ## - GEOGRAPHIC AREA CODE | |
| Geographic area code | n-us--- |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RM301.25 |
| Item number | P43 2001 |
| 245 00 - TITLE STATEMENT | |
| Title | Pharmaceutical technology assessment for managed care : |
| Remainder of title | current practice and suggestions for improvement / |
| Statement of responsibility, etc | Samuel A. Bozzette ... [et al.]. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE STATEMENTS | |
| Place of production, publication, distribution, manufacture | Santa Monica, CA : |
| Name of producer, publisher, distributor, manufacturer | RAND, |
| Date of production, publication, distribution, manufacture | 2001. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | xi, 74 pages : |
| Other physical details | illustrations ; |
| Dimensions | 28 cm |
| 336 ## - CONTENT TYPE | |
| Content Type Term | text |
| Content Type Code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media Type Term | computer |
| Media Type Code | c |
| Source | rdamedia |
| 337 ## - MEDIA TYPE | |
| Media Type Term | unmediated |
| Media Type Code | n |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier Type Term | online resource |
| Carrier Type Code | cr |
| Source | rdacarrier |
| 338 ## - CARRIER TYPE | |
| Carrier Type Term | volume |
| Carrier Type Code | nc |
| Source | rdacarrier |
| 500 ## - GENERAL NOTE | |
| General note | "RAND Health." |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc | Includes bibliographical references (p. 71-74). |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Powerful pharmaceuticals are of increasing clinical and economic importance to managed care organizations, which are often responsible for managing and paying for the increasing costs of pharmaceuticals. This creates an incentive for them to go beyond a focus on clinical effectiveness and safety to evaluate the cost-effectiveness of new drugs. This report describes the processes by which managed care organizations evaluate pharmaceutical technologies and suggests pathways for organizing improvement. It reviews current evaluation procedures, provides a framework for future evaluations, introduces evaluation approaches, and annotates resources for further research on each topic covered. The report finds that most managed care organizations have internal procedures for assessing new pharmaceutical technologies, but their medical directors commonly believe these procedures to be less rigorous and less systematic than are desirable. The decisionmaking framework outlined in the report and the techniques it incorporates describe an objective, reproducible process for assessing pharmaceutical technology in the managed care setting. It provides a "road map" that can help an organization expose hidden biases in current processes, build on its experiences with evaluation, and reduce the risk of illogical or poorly thought-through decisions. |
| 530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE | |
| Additional physical form available note | Also available on the internet via WWW in PDF format. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Managed care plans (Medical care) |
| Geographic subdivision | United States. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medical innovations |
| Geographic subdivision | United States |
| General subdivision | Evaluation. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Pharmaceutical technology |
| General subdivision | Effect of managed care on |
| Geographic subdivision | United States. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Pharmaceutical technology |
| Geographic subdivision | United States |
| General subdivision | Decision making. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Pharmaceutical technology |
| Geographic subdivision | United States. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Technology assessment |
| Geographic subdivision | United States. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bozzette, Samuel A. |
| Relator term | author. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | D'Amato, Rebecca. |
| Relator term | author. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Morton, Sally C. |
| Relator term | author. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Harris, Katherine M. |
| Relator term | author. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Meili, Robin. |
| Relator term | author. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Taylor, Roger. |
| Relator term | author. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | RAND Health. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | Rand Corporation. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | Sanofi-Synethlabo Inc. |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Link text | Online Access |
| Uniform Resource Identifier | <a href="http://www.rand.org/publications/MR/MR1206/">http://www.rand.org/publications/MR/MR1206/</a> |
No items available.